WO2007011644A3 - Compositions for regenerating defective or absent tissue - Google Patents
Compositions for regenerating defective or absent tissue Download PDFInfo
- Publication number
- WO2007011644A3 WO2007011644A3 PCT/US2006/027212 US2006027212W WO2007011644A3 WO 2007011644 A3 WO2007011644 A3 WO 2007011644A3 US 2006027212 W US2006027212 W US 2006027212W WO 2007011644 A3 WO2007011644 A3 WO 2007011644A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- organ
- defective
- damaged
- compositions
- extracellular matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention is to a composition for reconstruction, replacement or repair of a defect or damage in organ tissue comprising an emulsion, injectable solution, patch or other compositions or material forms comprising extracellular matrix. The organ can be any organ in the human body, for example, heart, brain, liver, kidney, pancreas or spleen. The ability to address organ damage or defects using extracellular matrix materials, including using minimally invasive surgery to contact the extracellular matrix with the damaged or defective organ tissue provide the opportunity to regenerate, replace or repair damaged or defective organ tissue that would otherwise remain defective or damaged or which would function suboptimally compared to healthy organ tissue.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/182,551 US8568761B2 (en) | 2005-07-15 | 2005-07-15 | Compositions for regenerating defective or absent myocardium |
US11/182,551 | 2005-07-15 | ||
US11/334,319 US20070014868A1 (en) | 2005-07-15 | 2006-01-18 | Patch for reconstruction, replacement or repair of the pericardial sac |
US11/334,631 | 2006-01-18 | ||
US11/334,631 US20070014869A1 (en) | 2005-07-15 | 2006-01-18 | Compositions for reconstruction, replacement or repair of intracardiac tissue |
US11/334,319 | 2006-01-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007011644A2 WO2007011644A2 (en) | 2007-01-25 |
WO2007011644A3 true WO2007011644A3 (en) | 2007-08-02 |
Family
ID=37669358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/027212 WO2007011644A2 (en) | 2005-07-15 | 2006-07-12 | Compositions for regenerating defective or absent tissue |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007011644A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8845719B2 (en) | 2011-05-27 | 2014-09-30 | Cormatrix Cardiovascular, Inc | Extracellular matrix material conduits and methods of making and using same |
US8980296B2 (en) | 2009-02-18 | 2015-03-17 | Cormatrix Cardiovascular, Inc. | Compositions and methods for preventing cardiac arrhythmia |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7666852B2 (en) * | 2002-04-22 | 2010-02-23 | Agenta Biotechnologies, Inc. | Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide |
US9532943B2 (en) | 2010-12-20 | 2017-01-03 | Cormatrix Cardiovascular, Inc. | Drug eluting patch for the treatment of localized tissue disease or defect |
US8983570B2 (en) | 2007-03-27 | 2015-03-17 | Cardiovascular Biotherapeutics, Inc. | Therapeutic angiogenesis for treatment of the spine |
US11224635B2 (en) * | 2007-03-27 | 2022-01-18 | Venturis Thereuptics, Inc. | Therapeutic angiogenesis for treatment of the spine and other tissues |
US9283302B2 (en) | 2011-12-16 | 2016-03-15 | Cormatrix Cardiovascular, Inc. | Extracellular matrix encasement structures and methods |
AU2009201915C1 (en) | 2008-08-22 | 2015-02-26 | Regeneus Ltd | Therapeutic methods |
CN102488925A (en) * | 2011-12-29 | 2012-06-13 | 成都普川生物医用材料股份有限公司 | Injectable articular cartilage tissue repair material and its preparation method |
US9801910B2 (en) | 2014-03-17 | 2017-10-31 | Ethicon, Inc. | Decellularized pleural matrix |
AU2015236088A1 (en) * | 2014-03-25 | 2016-11-10 | Cook Biotech Incorporated | Extracellular matrix grafts loaded with exogenous factors |
US10479980B2 (en) | 2015-01-30 | 2019-11-19 | Northwestern University | Artificial ovary |
CN104984398B (en) * | 2015-07-01 | 2018-03-30 | 上海交通大学医学院附属第九人民医院 | A kind of preparation method and application of injection type tissue engineering bone gel carrier |
WO2017008016A1 (en) * | 2015-07-09 | 2017-01-12 | The Board Of Regents Of The University Of Texas System | Nanoparticles containing extracellular matrix for drug delivery |
CN107080861B (en) * | 2017-03-03 | 2020-01-21 | 北京博辉瑞进生物科技有限公司 | High-induction-activity repair material, preparation method and application |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
US5554389A (en) * | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
US6099567A (en) * | 1996-12-10 | 2000-08-08 | Purdue Research Foundation | Stomach submucosa derived tissue graft |
WO2000061204A1 (en) * | 1999-04-12 | 2000-10-19 | Advanced Tissue Sciences, Inc. | Three-dimensional stromal tissue |
US20020061587A1 (en) * | 2000-07-31 | 2002-05-23 | Piero Anversa | Methods and compositions for the repair and/or regeneration of damaged myocardium |
WO2005042048A2 (en) * | 2003-10-22 | 2005-05-12 | Encelle, Inc. | Bioactive hydrogel compositions for regenerating connective tissue |
WO2006121532A2 (en) * | 2005-03-31 | 2006-11-16 | Mytogen, Inc. | Treatment for heart disease |
-
2006
- 2006-07-12 WO PCT/US2006/027212 patent/WO2007011644A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
US5554389A (en) * | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
US6099567A (en) * | 1996-12-10 | 2000-08-08 | Purdue Research Foundation | Stomach submucosa derived tissue graft |
WO2000061204A1 (en) * | 1999-04-12 | 2000-10-19 | Advanced Tissue Sciences, Inc. | Three-dimensional stromal tissue |
US20020061587A1 (en) * | 2000-07-31 | 2002-05-23 | Piero Anversa | Methods and compositions for the repair and/or regeneration of damaged myocardium |
WO2005042048A2 (en) * | 2003-10-22 | 2005-05-12 | Encelle, Inc. | Bioactive hydrogel compositions for regenerating connective tissue |
WO2006121532A2 (en) * | 2005-03-31 | 2006-11-16 | Mytogen, Inc. | Treatment for heart disease |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8980296B2 (en) | 2009-02-18 | 2015-03-17 | Cormatrix Cardiovascular, Inc. | Compositions and methods for preventing cardiac arrhythmia |
US8845719B2 (en) | 2011-05-27 | 2014-09-30 | Cormatrix Cardiovascular, Inc | Extracellular matrix material conduits and methods of making and using same |
Also Published As
Publication number | Publication date |
---|---|
WO2007011644A2 (en) | 2007-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007011644A3 (en) | Compositions for regenerating defective or absent tissue | |
WO2012002986A3 (en) | Decellularized and delipidized extracellular matrix and methods of use | |
WO2010039823A8 (en) | Compositions and methods for tissue repair with extracellular matrices | |
EP2664342A3 (en) | Native (telopeptide) placental collagen compositions | |
WO2010054013A3 (en) | Cell-scaffold constructs | |
BRPI0712088B8 (en) | use of a non-porous, fluid-tight, multi-layered, microscopic collagen lamina biomatrix | |
WO2007062082A3 (en) | Method and composition for repair and reconstruction of intervertebral discs and other reconstructive surgery | |
WO2007100530A3 (en) | Methods and compositions for the repair and/or regeneration of damaged myocardium | |
WO2006105167A3 (en) | Methods, compositions, and formulations for preventing or reducing adverse effects in a patient | |
WO2006071802A3 (en) | Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells | |
WO2012158952A8 (en) | Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells and hydrogel | |
GB2443938B (en) | Preparation of tissue for meniscal implantation | |
WO2009136291A3 (en) | Cellular extracts | |
WO2008013763A3 (en) | Packed demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation | |
WO2006138669A3 (en) | Life-like anatomic feature for testing injection of soft tissue fillers | |
Kaneko et al. | A 3D nanofibrous hydrogel and collagen sponge scaffold promotes locomotor functional recovery, spinal repair, and neuronal regeneration after complete transection of the spinal cord in adult rats | |
WO2006081435A3 (en) | Method of providing readily available cellular material derived from cord blood, and a composition thereof | |
WO2008019024A3 (en) | Bone graft composites and methods of treating bone defects | |
WO2009086305A3 (en) | Osteoinductive putties and methods of making and using such putties | |
WO2009057165A8 (en) | Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods | |
WO2005081870A3 (en) | Intervertebral disc repair, methods and devices therefor | |
WO2006093857A3 (en) | Method of providing readily available cellular material derived from peripheral blood and a composition thereof | |
WO2010127254A3 (en) | Thermoresponsive, biodegradable, elastomeric material and uses therefor | |
WO2007025215A3 (en) | Machine perfusion of tissue grafts for transplantation | |
WO2009022133A3 (en) | Scaffolds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06787156 Country of ref document: EP Kind code of ref document: A2 |